Skip to main content

Andrea Vilaplana Blanes

I have a degree in Biochemistry and Biomedical Sciences from the University of Valencia. Currently, I work as a researcher in the Cancer and Hematological Diseases Research Group at VHIR. I am part of the personalized medicine program where we work every day to find new therapeutic and molecular targets and guide patients' treatment according to the molecular alterations of their tumors.

Institutions of which they are part

Administration and Management
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Andrea Vilaplana Blanes

Institutions of which they are part

Administration and Management
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

I have a degree in Biochemistry and Biomedical Sciences from the University of Valencia. Currently, I work as a researcher in the Cancer and Hematological Diseases Research Group at VHIR. I am part of the personalized medicine program where we work every day to find new therapeutic and molecular targets and guide patients' treatment according to the molecular alterations of their tumors.

I studied Biochemistry and Biomedical Sciences degree at the University of Valencia between 2015 and 2019. I arrived in Barcelona in 2019 to start the Master in Translational Research at VHIR together with the Autonomous University of Barcelona.

My professional experience is focused on childhood cancer research. In 2020 I started working as Data Manager / Data Entry in the Pediatric Oncology and Hematology Area of Vall d'Hebron Hospital. Currently, since March 2022, I am part of the Research Group on Childhood Cancer and Hematological Diseases at VHIR, developing research tasks as well as database and project management activities.

My research activity is focused on the search for new biomarkers and molecular alterations in childhood tumors, especially in a specific subtype of solid tumor called neuroblastoma.

Thanks to the incorporation to the group I am a part of numerous national and international projects and research organizations. I am sure that these will help to improve the quality of life and the chances of survival of our patients.

Projects

BEACON-BIO: deep biological characterisation and development of biomarkers for relapsed neuroblastoma

IP: Lucas Moreno Martín-Retortillo
Collaborators: Andrea Vilaplana Blanes, BEACON-BIO: deep biological characterisation and development of biomarkers for relapsed neuroblastoma
Funding agency: European Science Foundation
Funding: 104500
Reference: BEACON-BIO_FKC_2021
Duration: 01/01/2022 - 30/09/2025

International integrated analysis to identify markers of poor survival in high-risk neuroblastoma

IP: Lucas Moreno Martín-Retortillo
Collaborators: Andrea Vilaplana Blanes, Mariona Morell Daniel
Funding agency: Solving Kids’ Cancer
Funding: 131766.91
Reference: SKC/AEFRM/2020/MORENO
Duration: 02/11/2020 - 01/11/2023

Related news

The €15,000 donation will boost research into this very rare type of childhood cancer.

The association has donated €15,088 to the Childhood Cancer and Blood Disorders group at VHIR to improve the treatment of rhabdomyosarcoma.

The Iris Association has made a €14,499 donation to the Childhood Cancer and Hematological Diseases Group at the Vall d’Hebron Research Institute (VHIR).

Related professionals

Simone Mameli

Simone Mameli

Predoctoral researcher
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more
Merce Albert Bayo

Merce Albert Bayo

Postdoctoral researcher
Transfusional Medicine
Read more
Arnau Cortés Nuet

Arnau Cortés Nuet

Technological Infrastructure Unit
Digital Transformation Directorate
Read more
Rubén Martínez Jaen

Rubén Martínez Jaen

Clinical Trials Management Unit
Clinical Research Development Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.